An Updated Meta-Analysis of Randomized Controlled Trials Assessing the Effect of Sorafenib in Advanced Hepatocellular Carcinoma

BACKGROUND: The efficacy of sorafenib in the treatment of advanced hepatocellular carcinoma (HCC) remains controversial. Therefore, we conducted a meta-analysis to evaluate the efficacy and safety of sorafenib for treating patients with advanced HCC. METHODS: The PubMed, Embase, and Web of Science d...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:PLoS One
Auteurs principaux: Peng, Songlin, Zhao, Yang, Xu, Feng, Jia, Changjun, Xu, Yongqing, Dai, Chaoliu
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2014
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4251972/
https://ncbi.nlm.nih.gov/pubmed/25460347
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0112530
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires